Cargando…
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
SIMPLE SUMMARY: Cannabinoids are mainly used for recreational purposes but find their way into oncology due to ongoing legalization efforts and anti-cancerous hints in the scientific literature. The goal of this study was to elucidate the mode of action of a clinically used cannabis medication in me...
Autores principales: | Richtig, Georg, Kienzl, Melanie, Rittchen, Sonja, Roula, David, Eberle, Jürgen, Sarif, Zina, Pichler, Martin, Hoefler, Gerald, Heinemann, Akos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215168/ https://www.ncbi.nlm.nih.gov/pubmed/37237519 http://dx.doi.org/10.3390/biology12050706 |
Ejemplares similares
-
Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
por: Richtig, Georg, et al.
Publicado: (2017) -
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
por: Richtig, Georg, et al.
Publicado: (2018) -
Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017) -
Therapeutic Potential of Hematopoietic Prostaglandin D(2) Synthase in Allergic Inflammation
por: Rittchen, Sonja, et al.
Publicado: (2019) -
ASCO Congress 2018: melanoma treatment
por: Richtig, Erika
Publicado: (2018)